focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.00
Bid: 75.60
Ask: 76.00
Change: -0.50 (-0.65%)
Spread: 0.40 (0.529%)
Open: 76.70
High: 77.00
Low: 75.50
Prev. Close: 76.50
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV and proposed placing under placing programme

4 Jul 2016 13:51

RNS Number : 1708D
GCP Infrastructure Investments Ltd
04 July 2016
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

This announcement is an advertisement and not a prospectus. Any decision to invest in any securities referred to in this announcement must be made exclusively on the basis of the prospectus published by the Company on 18 April 2016 in connection with a placing programme (the "Placing Programme") for ordinary shares of £0.01 each ("Ordinary Shares"), to be admitted to the Premium Listing segment of the Official List of the UK Listing Authority and to trading on the Main Market for listed securities of the London Stock Exchange (the "Prospectus"). A copy of the Prospectus is available for inspection at www.morningstar.co.uk/uk/NSM. This announcement does not constitute a recommendation regarding any securities.

 

GCP Infrastructure Investments Limited

(the "Company")

NAV AND PROPOSED PLACING UNDER PLACING PROGRAMME

Net asset value of the Company's shares

GCP Infrastructure Investments Limited, the only UK listed fund focused primarily on investments in UK infrastructure debt, announces that as at close of business on 30 June 2016, the unaudited net asset value per Ordinary Share of the Company was 107.73 pence. The net asset value takes into account cash, other assets, accrued liabilities and expenses and leverage (if any) of the Company.

Placing under the Placing Programme

The Board of Directors of the Company is pleased to announce a placing of new Ordinary Shares under the Placing Programme, seeking to raise up to c.£35 million of gross proceeds in accordance with the Prospectus published on 18 April 2016 (the "Placing").

The Placing Price has been set, having considered the net asset value as at 30 June 2016, at 116.5 pence per Ordinary Share. The Placing Price represents a discount of 4 pence per Ordinary Share (3.3 per cent.) to the closing price per Ordinary Share on 1 July 2016, the last day prior to the announcement of consideration of a placing, of 120.5 pence.

The Placing will be NAV accretive for existing shareholders.

The Placing is being proposed in order to allow the Company to take advantage of a number of attractive investment opportunities in the near term in accordance with the Company's investment objective and policy.

The Placing will be non pre-emptive and shall commence immediately following this announcement.

Qualified investors should communicate their firm interest to their usual sales contact at Stifel Nicolaus Europe Limited ("Stifel"), providing a clear indication of the number of new Ordinary Shares which such qualified investor wishes to subscribe for under the Placing.

The decision to allot any new Ordinary Shares to any qualified investors shall be at the discretion of the Company and Stifel. Stifel reserves the right, after consultation with the Company and the Investment Adviser, to scale back applications under the Placing at their absolute discretion in such amounts as they consider appropriate. The Placing is subject to the terms and conditions of the Placing Programme set out in the Prospectus published on 18 April 2016.

Applications will be made to the UK Listing Authority for all of the new Ordinary Shares issued pursuant to the Placing to be admitted to the premium segment of the Official List and for all such new Ordinary Shares to be admitted to trading on the London Stock Exchange's main market for listed securities. It is expected that such admission will become effective and dealings in such new Ordinary Shares will commence on 12 July 2016

The expected timetable for the Placing is set out below and is subject to change at the discretion of the Company and in consultation with Stifel

 

Expected timetable

 

2016

NAV as at 30 June 2016 announced and Placing opens

4 July

Latest time and date for receipt of placing commitments

12.00 p.m. on 8 July

Results of Placing announced and trade date

8 July

Admission and settlement

12 July

 

Unless otherwise defined herein, terms used in this announcement shall have the same meanings as those defined in the Prospectus dated 18 April 2016. 

Contact details:

Gravis Capital Partners LLP

Stephen Ellis

Rollo Wright

Dion Di Miceli

 

 +44 (0)20 7518 1490

 

 

Stifel Nicolaus Europe Limited 

Mark Bloomfield

Neil Winward

Tunga Chigovanyika

 

 

+44 (0)20 7710 7600

Buchanan

Charles Ryland

Victoria Hayns

 

 

+44 (0)20 7466 5000

Important Information

Members of the public are not eligible to take part in the Placing. This announcement and the terms and conditions referred to herein are directed in the United Kingdom only at persons selected by Stifel Nicolaus Europe Limited who are "investment professionals" falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "FPO") or "high net worth companies, unincorporated associations etc" falling within Article 49(2) of the FPO, or persons to whom it may otherwise be lawfully communicated (all such persons together being referred to as "Relevant Persons"). This announcement and the terms and conditions referred to herein must not be acted on or relied on in the United Kingdom by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to, and will be engaged in only with, persons in the United Kingdom who are Relevant Persons. 

The new Ordinary Shares that are the subject of the Placing are not being offered or sold to any person in the European Union, other than to "qualified investors" as defined in Article 2.1(e) of Directive 2003/71/EC, which includes legal entities which are regulated by the Financial Conduct Authority or entities which are not so regulated whose corporate purpose is solely to invest in securities. 

This announcement is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or South Africa or into any other jurisdiction where applicable laws prohibit its release, distribution or publication. This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or South Africa or in any other jurisdiction where such offer or sale would be unlawful. The securities of the Company have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or the US Investment Company Act of 1940, as amended and may not be offered or sold directly or indirectly in or into the United States or to or for the account or benefit of any US Person (within the meaning of Regulation S under the Securities Act). The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Australia, Canada, Japan or South Africa or to any national, resident or citizen of Australia, Canada, Japan or South Africa. 

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by, Stifel Nicolaus Europe Limited or by any of its affiliates or agents as to or in relation to the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or their advisers and any liability therefore is expressly disclaimed. 

Stifel Nicolaus Europe Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as sole broker and bookrunner to the Company and is acting for no-one else in connection with the Placing and the contents of this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Stifel Nicolaus Europe Limited nor for providing advice in connection with the Placing and the contents of this announcement or any other matter referred to herein.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVLZLFBQDFEBBB
Date   Source Headline
29th Apr 20222:33 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSInvestor Report at 31 March 2022
27th Apr 202211:47 amRNSDirector/PDMR Shareholding
26th Apr 20222:32 pmRNSHolding(s) in Company
25th Apr 20227:00 amRNSDirector/PDMR Shareholding
21st Apr 202211:26 amRNSDividend Declaration & Scrip Dividend Alternative
14th Apr 20224:12 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSNet Asset Value(s)
31st Mar 20227:00 amRNSTotal Voting Rights
8th Mar 20229:46 amRNSAdditional Listing and Total Voting Rights
24th Feb 20229:25 amRNSAdditional Listing
21st Feb 20227:00 amRNSDirector Declaration
14th Feb 20223:03 pmRNSResult of AGM
26th Jan 20221:26 pmRNSDirector/PDMR Shareholding
26th Jan 20221:24 pmRNSDirector/PDMR Shareholding
21st Jan 202212:10 pmRNSDividend Declaration & Scrip Dividend Alternative
21st Jan 20227:00 amRNSInvestor Report at 31 December 2021
18th Jan 20223:31 pmRNSUpdate research from QuotedData
17th Jan 20227:00 amRNSNet Asset Value(s)
10th Jan 20228:00 amRNSNotice of AGM
31st Dec 20217:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSDirector Declaration
14th Dec 20217:00 amRNSAnnual report and financial statements
9th Dec 202110:39 amRNSDirector/PDMR Shareholding
9th Dec 20218:41 amRNSAdditional Listing and Total Voting Rights
1st Dec 20217:00 amRNSDirectorate Change
29th Nov 202110:09 amRNSAdditional Listing
11th Nov 20217:00 amRNSScrip Share Reference Price
29th Oct 20217:00 amRNSInvestor Report at 30 September 2021
28th Oct 20211:54 pmRNSDividend Declaration & Scrip Dividend Alternative
19th Oct 20217:00 amRNSNet Asset Value(s)
30th Sep 20217:00 amRNSTotal Voting Rights
17th Sep 20215:23 pmRNSNew Directorship Notification
9th Sep 202111:47 amRNSDirector/PDMR Shareholding
9th Sep 202111:47 amRNSAdditional Listing and Total Voting Rights
3rd Sep 20214:15 pmRNSNew Directorship Notification
27th Aug 202110:19 amRNSAdditional Listing
12th Aug 20217:00 amRNSScrip share reference price
9th Aug 202111:42 amRNSHolding(s) in Company
30th Jul 20217:00 amRNSInvestor Report at 30 June 2021 and RCF update
28th Jul 20217:00 amRNSDividend Declaration & Scrip Dividend Alternative
20th Jul 202110:59 amRNSUpdate research from QuotedData
16th Jul 20219:21 amRNSDirector/PDMR Shareholding
15th Jul 20217:00 amRNSNet Asset Value(s)
1st Jul 202110:55 amRNSHolding(s) in Company
30th Jun 20217:00 amRNSTotal Voting Rights
22nd Jun 202110:20 amRNSDirector/PDMR Shareholding
21st Jun 20211:21 pmRNSDirector/PDMR Shareholding
10th Jun 20217:00 amRNSHalf-yearly report and financial statements 2021
8th Jun 202112:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.